Book contents
- Advance Praise for The Cambridge Handbook of Public-Private Partnerships, Intellectual Property Governance, and Sustainable Development
- The Cambridge Handbook of Public–Private Partnerships, Intellectual Property Governance, and Sustainable Development
- The Cambridge Handbook of Public–Private Partnerships, Intellectual Property Governance, and Sustainable Development
- Copyright page
- Contents
- Figures
- Tables
- Contributors
- Foreword
- Acknowledgments
- Glossary
- Introduction
- Part I Public Health
- 2 Public–Private Partnerships as Models for New Drug Research and Development: The Future as Now
- 3 Driving Innovation for Global Health through Multi-stakeholder Partnerships
- 4 Creating, Managing, and Advancing Collaborations: The Road to Successful Partnerships
- 5 Patent Pooling in Public Health
- 6 Intellectual Property in Early-Phase Research Public–Private Partnerships in the Biomedical Sector
- Part II Education, ICT, and Libraries
- Part III Environmental Issues: Green Technologies and Agriculture
- Part IV Governance and Institutional Design Perspectives
- Conclusion
- References
5 - Patent Pooling in Public Health
from Part I - Public Health
Published online by Cambridge University Press: 14 September 2018
Book contents
- Advance Praise for The Cambridge Handbook of Public-Private Partnerships, Intellectual Property Governance, and Sustainable Development
- The Cambridge Handbook of Public–Private Partnerships, Intellectual Property Governance, and Sustainable Development
- The Cambridge Handbook of Public–Private Partnerships, Intellectual Property Governance, and Sustainable Development
- Copyright page
- Contents
- Figures
- Tables
- Contributors
- Foreword
- Acknowledgments
- Glossary
- Introduction
- Part I Public Health
- 2 Public–Private Partnerships as Models for New Drug Research and Development: The Future as Now
- 3 Driving Innovation for Global Health through Multi-stakeholder Partnerships
- 4 Creating, Managing, and Advancing Collaborations: The Road to Successful Partnerships
- 5 Patent Pooling in Public Health
- 6 Intellectual Property in Early-Phase Research Public–Private Partnerships in the Biomedical Sector
- Part II Education, ICT, and Libraries
- Part III Environmental Issues: Green Technologies and Agriculture
- Part IV Governance and Institutional Design Perspectives
- Conclusion
- References
Summary
Patent pooling is a relatively new concept in public health that has emerged as an innovative public-private partnership mechanism for the public health management of intellectual property rights with a view to facilitating access and innovation. The success of the Medicines Patent Pool (MPP) as the first patent pool in public health provides lessons on the implementation of this kind of mechanism in the health field. Through its clear public health mandate, access-oriented licensing terms, inclusive governance structure, emphasis on transparency and extensive partnerships, the MPP has proven to be a model that can contribute addressing specific public health challenge. It could also potentially be adapted to address other innovation or access-related challenges in public health. These include disease areas where patent pooling can enhance access to affordable health products in resource-limited settings; instances in which licensing can facilitate follow-on research; areas in which innovative incentives can be combined with patent pooling to facilitate research and development; and situations in which patent pooling can contribute to overcoming patent thickets.
- Type
- Chapter
- Information
- The Cambridge Handbook of Public-Private Partnerships, Intellectual Property Governance, and Sustainable Development , pp. 93 - 108Publisher: Cambridge University PressPrint publication year: 2018
References
3P: Pull. Pool, Push, The Access Campaign, Better TB treatment. Faster. Proposal to accelerate innovation and access to new treatment regimens for TB, www.msfaccess.org/sites/default/files/TB_3P2pager_Dec-2015_ENG.pdf (last visited Nov. 21, 2017).Google Scholar
Access to Medicines Foundation, Index 2014, https://accesstomedicinefoundation.org/media/atmf/2014-Access-to-Medicine-Index.pdf. (last visited Nov. 21, 2017).Google Scholar
Burrone, Esteban and Perry, Greg, Ensuring New Medicines Reach Those in Most Need, 2 Lancet HIV e362 (2015).Google Scholar
Buse, Kent and Walt, Gill, Global Public–Private Partnerships: Part II – What are the Health Issues for Global Governance?, 78 Bull. World Health Organ. (2000).Google Scholar
Chatham House, Towards a New Global Business Model for Antibiotics: Delinking Revenue From Sales (2015).Google Scholar
Contreras, Jorge, Bermuda’s Legacy: Policy, Patents, and the Design of the Genome Commons, 12 Minn. J. L. Sci. & Tech. 61 (2011).Google Scholar
Friede, Martin, Prieels, Jean-Paul, Spooren, Anneleen, and Mottrie, Mathieu, Innovation for Vaccines Against Poverty Diseases: The Need for New Support Mechanisms (2014), www.who.int/immunization/research/forums_and_initiatives/02_Friede_Business_Model.pdf (last visited Nov. 23, 2017).Google Scholar
Int’l Fed’n of Pharm. Mfrs. & Ass’n, Declaration by the Pharmaceutical, Biotechnology and Diagnostics Industries on Combating Antimicrobial Resistance (Jan. 2016), www.ifpma.org/partners-2/declaration-by-the-pharmaceutical-biotechnology-and-diagnostics-industries-on-combating-antimicrobial-resistance-amr/ (last visited Nov. 23, 2017).Google Scholar
Juneja, Sandeep, Gupta, Aastha, Moon, Suerie and Resch, Stephen, Projected savings through public health voluntary licences of HIV drugs negotiated by the Medicines Patent Pool (MPP), PLoS ONE 12(5): e0177770 (2017), available at: https://doi.org/10.1371/journal.pone.0177770.CrossRefGoogle ScholarPubMed
Kieny, Maurie-Paule, Creating and Intergovernmental Consortium for New Antibiotics: A New Development Model, AMR Control (2015).Google Scholar
Medicines Patent Pool, Licenses in the MPP, www.medicinespatentpool.org/current-licences/(last visited Nov. 23, 2017).Google Scholar
Medicines Patent Pool, The Medicines Patent Pool Announces First Licence for Tuberculosis Treatment, MPP (Jan. 25, 2017), www.medicinespatentpool.org/the-medicines-patent-pool-announces-first-licence-for-tuberculosis-treatment/(last visited Nov. 23, 2017).Google Scholar
Medicines Patent Pool, The Medicines Patent Pool Expands Mandate to Hepatitis C and Tuberculosis Treatment (Nov.6, 2015), www.medicinespatentpool.org/the-medicines-patent-pool-expands-mandate-to-hepatitis-c-and-tuberculosis-treatment/ (last visited Nov. 21, 2017) (last visited Nov. 23, 2017).Google Scholar
Medicines Patent Pool, The Medicines Patent Pool Transparency Policy, MPP, https://medicinespatentpool.org/uploads/2017/07/MEDICINES-PATENT-POOL-TRANSPARENCY-POLICY-301014.pdf (last visited Nov. 23, 2017).Google Scholar
Medicines Patent Pool, Progress and Achievements of the Medicines Patent Pool 2010–2015 (2015).Google Scholar
Medicines Patent Pool, Target Medicines, www.medicinespatentpool.org/ourwork/target-medicines/(last visited Nov. 23, 2017).Google Scholar
Merges, Robert P., Institutions for Intellectual Property Transactions: The Case for Patent Pools (1999), www.law.berkeley.edu/files/pools%281%29.pdf (last visited Nov. 23, 2017).Google Scholar
Review on Antimicrobial Resistance, Securing New Drugs for Future Generations: The Pipeline of Antibiotics (2015), https://amr-review.org/sites/default/files/SECURING%20NEW%20DRUGS%20FOR%20FUTURE%20GENERATIONS%20FINAL%20WEB_0.pdf (last visited Nov. 21, 2017).Google Scholar
Shapiro, Carl, Navigating the Patent Thicket: Cross Licenses, Patent Pools, and Standard-Setting, 1 The Innovation Pol’y and the Econ. 119 (2011).Google Scholar
Simon, James H.M., Claasen, Eric., Correa, Carmen E., and Osterhaus, Albert D.M.E., Managing Severe Acute Respiratory Syndrome (SARS) Intellectual Property Rights: The Possible Role of Patent Pooling, 83 Bull. World Health Org. 707 (2005), www.who.int/bulletin/volumes/83/9/707.pdf (last visited Nov. 23, 2017).Google ScholarPubMed
United Nations, Human Rights Council Resolution 15/6, U.N. D.oc. A/HRC/15/L.28 (Sep. 27, 2010).Google Scholar
U.S. Patent and Trade Office, Patent Pools: A Solution to The Problem of Access in Biotechnology Patents? (2000), www.consultstanton.com/wp-content/uploads/2015/02/PATENT-POOL-WHITE-PAPER.pdf (last visited Nov. 23, 2017).Google Scholar
Van Overwalle, Geertrui (ed.), Cambridge University Press, Gene Patents and Collaborative Licensing Models: Patent Pools, Clearinghouses, Open Source Models and Liability Regimes (2009).Google Scholar
World Health Assembly, Global Action Plan on Antimicrobial Resistance, WHA68.7 (May 26, 2015).Google Scholar
World Health Organization, Accelerating Innovation and Access to Medicines for Tuberculosis through Open Collaboration: A Push, Pull, Pool Approach (“the 3P Project”) (2010), www.who.int/phi/implementation/10_summary_EN.pdf (last visited Nov. 23, 2017).Google Scholar
World Health Organization, Global Action Plan on Anti-Microbial Resistance (2015), http://apps.who.int/iris/bitstream/10665/193736/1/9789241509763_eng.pdf?ua=1 (last visited Nov. 23, 2017).Google Scholar
World Health Organization, Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property (2011), www.who.int/phi/publications/Global_Strategy_Plan_Action.pdf (last visited Nov. 23, 2017).Google Scholar
World Health Organization, Report of the Commission on Intellectual Property Rights, Innovation and Public Health (2006).Google Scholar
World Health Organization, Research and Development to Meet Health Needs in Developing Countries: Strengthening Global Financing and Coordination. Report of the Consultative Expert Working Group on Research and Development: Financing and Coordination (2012), www.who.int/phi/CEWG_Report_5_April_2012.pdf (last visited Nov. 23, 2017).Google Scholar
World Health Organization, Summary Report on the nomination of Experts and the shortlisting of Health R&D Demonstration Projects (2013), www.who.int/phi/implementation/EURO_procedure_for_selection_of_demo_projects.pdf (last visited Nov. 23, 2017).Google Scholar
World Trade Organization, World Intellectual Property Organization, World Health Organization, Promoting Access to Medical Technologies and Innovation (2012).Google Scholar
- 2
- Cited by